Capula Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$117K Sell
400
-200
-33% -$65.7K ﹤0.01% 867
2025
Q4
$210K Buy
600
+200
+50% +$67.6K ﹤0.01% 583
2025
Q3
$129K Buy
400
+100
+33% +$31.1K ﹤0.01% 689
2025
Q2
$117K Buy
+300
New +$121K ﹤0.01% 479
2021
Q1
Sell
-5,000
Closed -$1.6M 510
2020
Q4
$1.6M Buy
+5,000
New +$1.53M 0.08% 185

Other funds holding ELV

Capula Management's ELV Position: Q1 2026 in Review

Capula Management opened a new position in Elevance Health (ELV) in Q1 2026: 250 shares worth $73.2K. The stake represents ﹤0.01% of the portfolio and ranks #946 among its holdings. This is a return to the name: Capula Management previously reported a position in ELV as recently as Q3 2025.

Capula Management first reported a position in ELV in Q4 2020 and has held it in 14 quarters since. The position peaked at $2.43M in Q4 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Capula Management held 250 shares of Elevance Health worth $73.2K as of Q1 2026.
  • Elevance Health was a new Capula Management position in Q1 2026.
  • Elevance Health made up ﹤0.01% of Capula Management's portfolio in Q1 2026, its #946 holding.
  • Capula Management first reported a position in Elevance Health in Q4 2020 and has held it in 14 quarters since.
  • Capula Management's Elevance Health position peaked at $2.43M in Q4 2022.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.